Interleukin-6 gene alleles affect the risk of Alzheimer’s disease and levels of the cytokine in blood and brain
- 10 March 2003
- journal article
- clinical trial
- Published by Elsevier in Neurobiology of Aging
- Vol. 24 (7) , 921-926
- https://doi.org/10.1016/s0197-4580(03)00013-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Effects of IL6 and IL1β on aFGF expression and excitotoxicity in NT2N cellsJournal of Neuroimmunology, 2002
- Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?Journal of Neuroimmunology, 2000
- Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer’s diseaseJournal of Psychiatric Research, 1999
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.Journal of Clinical Investigation, 1998
- Longitudinal Study of Inflammatory Factors in Serum, Cerebrospinal Fluid, and Brain Tissue in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1998
- Increased cytokine production in mononuclear cells of healthy elderly peopleEuropean Journal of Immunology, 1993
- Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991
- Patterns of gliosis in alzheimer's disease and aging cerebrumGlia, 1989